De novo chromosome 7q36.1q36.2 triplication in a child with developmental delay, growth failure, distinctive facial features, and multiple congenital anomalies: a case report.

BMC Med Genet 2017 10 23;18(1):118. Epub 2017 Oct 23.

Division of Clinical Genetics and Metabolic Disorders, Pediatric Department, Tawam Hospital, Al-Ain, United Arab Emirates.

Background: Studying human genome using chromosomal microarrays has significantly improved the accuracy and yield of diagnosing genomic disorders. Chromosome 7q36 deletions and duplications are rare genomic disorders that have been reported in a limited number of children with developmental delay, growth retardation, and congenital malformation. Altered dosage of SHH and HLXB9, both located in 7q36.3, is believed to play roles in the phenotypes associated with these rearrangements. In this report we describe a child with 7q36.1q36.2 triplication that is proximal to the 7q36.3 region. In addition to the clinical description, we discuss the genes located in the triplicated region.

Case Presentation: We report a 22 month old male child with a de novo 1.35 Mb triplication at 7q36.1q36.2. His prenatal course was complicated by oligohydramnios, intrauterine growth restriction, and decreased fetal movement. Hypotonia, respiratory distress, and feeding difficulty were observed in the neonatal period. He also had developmental delay, cardiovascular malformation, growth failure with microcephaly, short stature, and underweight, sensorineural hearing loss, myopia, astigmatism, cryptorchidism, hypospadias, microphallus, lower extremity length discrepancy, bifid uvula, single palmer creases, and distinctive facial features including straight eyebrows, ptosis, up-slanted palpebral fissures, broad nasal bridge, low-set and posteriorly rotated ears, small mouth with thick lower lip, microretrognathia, and high-arched palate.

Conclusions: The child presented here had developmental delay, distinctive facial features, multiple congenital anomalies, and 7q36.1q36.2 triplication. This triplication, which was found to be de novo, has not been previously described and is believed to result in the observed phenotype. The triplicated region harbors the GALNTL5, GALNT11, KMT2C, XRCC2, and ACTR3B genes. GALNT11 encodes a membrane-bound polypeptide N-acetylgalactosaminyltransferase that can O-glycosylate NOTCH1 leading to the activation of the Notch signaling pathway. Therefore, increased GALNT11 dosage can potentially alter the Notch signaling pathway explaining the pathogenicity of 7q36 triplication. Studying further cases with similar genomic rearrangements is needed to make final conclusions about the pathogenicity of this triplication.

Download full-text PDF

Source Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
October 2017
14 Reads

Publication Analysis

Top Keywords

developmental delay
facial features
7q361q362 triplication
distinctive facial
congenital anomalies
delay growth
multiple congenital
growth failure
genomic disorders
notch signaling
features multiple
signaling pathway
distress feeding
xrcc2 actr3b
feeding difficulty
respiratory distress
fetal movement
decreased fetal
encodes membrane-bound


(Supplied by CrossRef)
Article in Am J Hum Genet
DT Miller et al.
Am J Hum Genet 2010
Article in J Mol Diagn
B Xiang et al.
J Mol Diagn 2010
Article in Am J Med Genet A
S Ayub et al.
Am J Med Genet A 2016
Article in Am J Med Genet A
K Wong et al.
Am J Med Genet A 2015
Article in Clin Dysmorphol
KA Bear et al.
Clin Dysmorphol 2012
Article in Eur J Med Genet
L Kroeldrup et al.
Eur J Med Genet 2012
Article in Biochem Biophys Res Commun
C Peng et al.
Biochem Biophys Res Commun 2010
Article in Science
JA Daniel et al.
Science 2010
Article in J Med Genet
J-Y Park et al.
J Med Genet 2016
Article in Eur J Biochem
P Jay et al.
Eur J Biochem 2000

Similar Publications